# Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case

**Authors:** Chuifeng Fan, Lianhe Yang, Xuyong Lin, Enhua Wang

PMC · DOI: 10.1186/s13000-015-0384-z · Diagnostic Pathology · 2015-08-28

## TL;DR

This paper reports a rare case of pseudomyogenic hemangioendothelioma in a 49-year-old woman with a long disease history and tumor recurrence.

## Contribution

The paper presents a rare case with a long clinical course and lymph node involvement, highlighting diagnostic challenges and tumor behavior.

## Key findings

- The tumor showed morphological diversity and specific immunohistochemical profiles that helped confirm the diagnosis.
- The case exhibited a relatively indolent behavior with delayed lymph node involvement after 10 years.
- The tumor was distinguished from epithelioid sarcoma and other soft tissue neoplasms through immunohistochemical markers.

## Abstract

Pseudomyogenic hemangioendothelioma is an extremely rare soft tissue tumor, also named as epithelioid sarcoma-like hemangioendothelioma, which occurs more frequently in young adult males. It was originally recognized as a variant of epitheloid sarcoma, however it is now concluded as a distinctive, rarely metastasizing endothelial neoplasm. We present a case of pseudomyogenic hemangioendothelioma in the lower limb in a 49-year-old female who has a long course of disease and suffered from twice local recurrences and lymph node affection of the tumor. The mass was subcutaneous and the margins were ill-defined. Morphologically, the tumor cells show diversity, composed of large spindle cells and round cells, both with abundant eocinophilic cytoplasm, mimicking rhybdomyoplasts and epitheloid cells respectively. The tumor cells show diffuse strong expression of Factor VIII, Fli-1, INI-1, vimentin, MDM2, and CDK4, local expression of CD31, AE1/AE3, EMA and P63, and no expression of CD34, S-100, actin-sm, desmin, MyoD1, and HMB45. Based on these information, this case is diagnosed as pseudomyogenic hemangioendothelioma after ruling out the main differential diagnosises including epithelioid sarcoma, malignant peripheral nerve sheath tumor and rhabdomyosarcoma. From this case we suggest that pseudomyogenic hemangioendothelioma may be confused with a variety of soft tissue neoplasm histologically. The clinical feature of the case of a long course of disease with twice local recurrences and final lymph node involvement 10 years after excision of the primary tumor indicates a relative indolent behavior of this tumor.

## Linked entities

- **Proteins:** FLI1 (Fli-1 proto-oncogene, ETS transcription factor), SMARCB1 (SWI/SNF related BAF chromatin remodeling complex subunit B1), PRELID1 (PRELI domain containing 1), MDM2 (MDM2 proto-oncogene), CDK4 (cyclin dependent kinase 4), PECAM1 (platelet and endothelial cell adhesion molecule 1), ETFA (electron transfer flavoprotein subunit alpha), RPE65 (retinoid isomerohydrolase RPE65), CD34 (CD34 molecule), S100A1 (S100 calcium binding protein A1), LOC101066771 (desmin-like), MYOD1 (myogenic differentiation 1), PMEL (premelanosome protein)
- **Diseases:** pseudomyogenic hemangioendothelioma (MONDO:0975754), epithelioid sarcoma (MONDO:0004105), malignant peripheral nerve sheath tumor (MONDO:0004345), rhabdomyosarcoma (MONDO:0005212)

## Full-text entities

- **Genes:** MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193] {aka ACTFS, HDMX, LSKB, hdm2}, KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, MYOD1 (myogenic differentiation 1) [NCBI Gene 4654] {aka CMYO17, CMYP17, MYF3, MYOD, MYODRIF, PUM}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, SLC4A3 (solute carrier family 4 member 3) [NCBI Gene 6508] {aka AE3, CAE3/BAE3, SLC2C, SQT7}, FLI1 (Fli-1 proto-oncogene, ETS transcription factor) [NCBI Gene 2313] {aka BDPLT21, EWSR2, FLI-1, SIC-1}, SLC4A1 (solute carrier family 4 member 1 (Diego blood group)) [NCBI Gene 6521] {aka AE1, BND3, CD233, CHC, DI, EMPB3}, SMARCB1 (SWI/SNF related BAF chromatin remodeling complex subunit B1) [NCBI Gene 6598] {aka BAF47, CSS3, INI-1, INI1, MRD15, PPP1R144}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, VIM (vimentin) [NCBI Gene 7431], KRT18 (keratin 18) [NCBI Gene 3875] {aka CK-18, CYK18, K18}, CDK4 (cyclin dependent kinase 4) [NCBI Gene 1019] {aka CMM3, MCPH31, PSK-J3}, CD34 (CD34 molecule) [NCBI Gene 947], AE1/AE3 [NCBI Gene 6521;6508], DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, MLANA (melan-A) [NCBI Gene 2315] {aka MART-1, MART1}
- **Diseases:** peripheral nerve sheath tumor (MESH:D018317), auto-immune diseases (MESH:C538437), epithelioid sarcoma-like hemangioendothelioma (MESH:D018323), Malignant peripheral nerve sheath tumor (MESH:D018319), Pseudomyogenic hemangioendothelioma (MESH:D006390), rhabdomyosarcoma (MESH:D012208), lymph node (MESH:D000072717), Lymph node metastasis (MESH:D008207), mesenchymal tumors (MESH:C535700), Epithelioid sarcoma (MESH:D012509), inflammation (MESH:D007249), Spindle tumor (MESH:D002277), Leiomyosarcoma (MESH:D007890), soft tissue neoplasm (MESH:D012983), metastasis (MESH:D009362), Cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4552433/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4552433/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC4552433/full.md

---
Source: https://tomesphere.com/paper/PMC4552433